V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220006949 | 220002698 | 1.75 | 82 | Palliative (P) | 2016-09-16 | 2016-09-21 | AML16 DA 3+10 | N | null | 220031364 | AML16 TRIAL |
| 220006950 | 220002698 | 1.82 | 94 | Palliative (P) | 2016-10-31 | 2016-11-16 | GemCarbo Days 1+8 | 02 | null | 220031364 | GEMCARBO |
| 220006951 | 220002699 | 1.77 | 58 | Palliative (P) | 2013-11-06 | 2013-11-12 | GemCarbo Days 1+8 | N | N | 220031374 | GEMCARBO |
| 220006952 | 220002700 | null | 61 | Palliative (P) | 2016-09-17 | 2016-10-27 | AML16 Low Dose Cytarabine | N | N | 220031375 | AML16 TRIAL |
| 220006953 | 220002701 | null | 126 | Palliative (P) | 2013-01-26 | 2013-02-03 | AML16 DA 3+10 | N | N | 220031376 | AML16 TRIAL |
| 220006954 | 220002702 | 0 | 94.7 | Curative (C) | null | 2016-07-21 | AML 18 TRIAL | 01 | N | 220031377 | AML18 TRIAL |
| 220006955 | 220002703 | 1.63 | 72.6 | Palliative (P) | 2017-11-05 | 2017-11-05 | CARBOPLATIN + PACLITAXEL | N | null | 220031380 | CARBOPLATIN + PACLITAXEL |
| 220006957 | 220002705 | 1.59 | 58 | Palliative (P) | 2016-09-29 | 2016-10-08 | Dasatinib | N | N | 220031382 | DASATINIB |
| 220006958 | 220002705 | 1.82 | 61 | Curative (C) | 2015-02-13 | 2015-02-13 | AML18 PILOT TRIAL | N | N | 220031382 | PILOT TRIAL |
| 220006959 | 220002705 | 1.54 | 126 | Palliative (P) | 2016-01-13 | 2016-02-18 | AML16 DA 3+10 | Y | N | 220031382 | AML16 TRIAL |
| 220006960 | 220002706 | null | 53.3 | Curative (C) | null | 2015-08-01 | AML 18 TRIAL | Y | null | 220031392 | AML18 TRIAL |
| 220006961 | 220002707 | 1.76 | 51.5 | Palliative (P) | 2016-06-29 | 2016-06-30 | Idarubicin+Tretinoin Spanish Crse2 | N | Y | 220031393 | IDARUBICIN + TRETINOIN |
| 220006962 | 220002708 | 1.72 | 73.1 | Curative (C) | 2013-05-04 | 2013-06-05 | AML16 Azacitidine | N | null | 220031395 | AML16 TRIAL |
| 220006963 | 220002709 | 0 | 82 | Palliative (P) | 2015-05-30 | 2015-06-05 | AML16 DA 3+10 | N | N | 220031398 | AML16 TRIAL |
| 220006964 | 220002710 | 1.7 | 62 | Curative (C) | 2016-03-24 | 2016-03-25 | Idarubicin+Tretinoin Spanish Crse1 | N | null | 220031399 | IDARUBICIN + TRETINOIN |
| 220006965 | 220002710 | 1.57 | 93.4 | Neo-adjuvant (N) | 2016-06-04 | 2016-06-08 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220031399 | CARBOPLATIN + PACLITAXEL |
| 220006966 | 220002711 | 1.56 | 79 | Palliative (P) | 2017-11-15 | 2017-11-22 | Dasatinib | 2 | N | 220031402 | DASATINIB |
| 220006967 | 220002712 | 1.69 | 71 | Palliative (P) | 2014-06-20 | 2014-06-22 | Idarubicin+Tretinoin Spanish Crse1 | N | Y | 220031403 | IDARUBICIN + TRETINOIN |
| 220006968 | 220002713 | null | 71.6 | Curative (C) | 2016-01-14 | 2016-01-22 | AML16 Low Dose Cytarabine | N | N | 220031405 | AML16 TRIAL |
| 220006969 | 220002713 | 1.67 | 72.2 | Palliative (P) | 2015-08-26 | 2015-08-26 | GemCarbo Days 1+8 | 02 | N | 220031405 | GEMCARBO |
| 220006970 | 220002713 | 0 | 77.6 | Palliative (P) | 2014-05-21 | 2014-05-26 | Dasatinib | 2 | N | 220031405 | DASATINIB |
| 220006971 | 220002714 | 1.78 | 78 | Palliative (P) | 2017-03-21 | 2017-04-22 | AML16 DA 3+8 | Y | Y | 220031413 | AML16 TRIAL |
| 220006972 | 220011554 | null | 77 | null | 2014-05-17 | 2014-05-17 | Idarubicin+Tretinoin Spanish Crse1 | N | N | 220031414 | IDARUBICIN + TRETINOIN |
| 220006973 | 220011554 | 1.6 | 78.8 | null | 2017-04-21 | 2017-04-21 | AML 18 TRIAL | 1 | N | 220031414 | AML18 TRIAL |
| 220006974 | 220011554 | 1.75 | 85.2 | Curative (C) | 2015-11-03 | 2015-11-04 | AML 18 Pilot Trial | Y | N | 220031414 | PILOT TRIAL |
| 220006975 | 220011554 | 1.74 | null | Palliative (P) | 2017-11-29 | 2017-12-08 | CARBOPLATIN + GEMCITABINE | N | N | 220031414 | GEMCARBO |
| 220006976 | 220011554 | 1.73 | 84 | Palliative (P) | 2017-10-29 | 2017-11-08 | GemCarbo Days 1+8 | 02 | N | 220031414 | GEMCARBO |
| 220006977 | 220002715 | 1.76 | null | Palliative (P) | 2017-08-20 | 2017-08-20 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 220031424 | CISPLATIN + GEMCITABINE |
| 220006978 | 220011555 | 1.52 | 90.6 | Palliative (P) | 2017-04-14 | 2017-04-14 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 220031428 | CISPLATIN + GEMCITABINE |
| 220006979 | 220011555 | 1.76 | 90 | Curative (C) | null | 2013-04-13 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 220031428 | CARBOPLATIN + PACLITAXEL |
| 220006980 | 220011555 | null | 63.2 | Palliative (P) | 2016-07-23 | 2016-07-24 | GemCarbo Days 1+8 | N | N | 220031428 | GEMCARBO |
| 220006981 | 220011555 | 1.7 | null | Curative (C) | 2013-12-03 | 2013-12-06 | AML 18 Pilot Trial | Y | N | 220031428 | PILOT TRIAL |
| 220006982 | 220011555 | 1.61 | 47.2 | Palliative (P) | 2014-03-20 | 2014-03-22 | CISPLATIN + GEMCITABINE | N | N | 220031428 | CISPLATIN + GEMCITABINE |
| 220006983 | 220011555 | 1.7 | 84.5 | Palliative (P) | 2017-01-22 | 2017-02-02 | Dasatinib | 2 | N | 220031428 | DASATINIB |
| 220006984 | 220022009 | 1.62 | 76.8 | Curative (C) | 2015-07-30 | 2015-07-30 | IDARUBICIN + TRETINOIN | N | N | 220031441 | IDARUBICIN + TRETINOIN |
| 220006985 | 220002716 | 1.78 | 81 | Neo-adjuvant (N) | 2013-07-24 | 2013-07-24 | AML 18 TRIAL | Y | N | 220031445 | AML18 TRIAL |
| 220006986 | 220002716 | 1.6 | 88 | Palliative (P) | 2013-03-23 | 2013-04-15 | Carboplatin 21day + Paclitaxel 7day | 02 | N | 220031445 | CARBOPLATIN + PACLITAXEL |
| 220006987 | 220002716 | 1.73 | 68 | Curative (C) | 2013-08-14 | 2013-09-23 | AML16 DA 3+10 | Y | N | 220031445 | AML16 TRIAL |
| 220006997 | 220002719 | null | 87 | Palliative (P) | 2013-11-28 | 2013-12-26 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220031471 | CARBOPLATIN + PACLITAXEL |
| 220006998 | 220002720 | 1.7 | 109 | Curative (C) | null | 2013-06-10 | AML 18 TRIAL | Y | N | 220031473 | AML18 TRIAL |
| 220006999 | 220002721 | 1.68 | 67 | Curative (C) | 2014-12-28 | 2014-12-31 | AML16 Azacitidine | N | null | 220031475 | AML16 TRIAL |
| 220007000 | 220002722 | 1.8 | 82 | Palliative (P) | null | 2015-04-20 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 220031476 | CISPLATIN + GEMCITABINE |
| 220007001 | 220002722 | 1.47 | 47.5 | Palliative (P) | 2017-02-11 | 2017-02-11 | CARBOPLATIN + PACLITAXEL | 02 | N | 220031476 | CARBOPLATIN + PACLITAXEL |
| 220007002 | 220002722 | 1.63 | 74 | null | 2014-07-03 | 2014-07-15 | CARBOPLATIN + PACLITAXEL | 2 | N | 220031476 | CARBOPLATIN + PACLITAXEL |
| 220007003 | 220002722 | 1.66 | 59.9 | Curative (C) | null | 2016-08-14 | AML16 Low Dose Cytarabine | N | N | 220031476 | AML16 TRIAL |
| 220007004 | 220002722 | 1.57 | 58.2 | Curative (C) | 2013-08-05 | 2013-08-05 | IDARUBICIN + TRETINOIN | N | N | 220031476 | IDARUBICIN + TRETINOIN |
| 220007005 | 220002722 | 1.73 | 77 | Palliative (P) | null | 2014-07-18 | CISPLATIN + GEMCITABINE | null | N | 220031476 | CISPLATIN + GEMCITABINE |
| 220007006 | 220002723 | 1.82 | 87 | Palliative (P) | null | 2015-07-16 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220031486 | CARBOPLATIN + PACLITAXEL |
| 220007007 | 220002724 | 1.73 | 87 | Palliative (P) | 2013-10-31 | 2013-11-14 | Idarubicin+Tretinoin Spanish Crse4 | null | N | 220031491 | IDARUBICIN + TRETINOIN |
| 220007008 | 220002724 | 1.87 | 64 | Palliative (P) | null | 2013-08-05 | CISPLATIN + GEMCITABINE | 02 | N | 220031491 | CISPLATIN + GEMCITABINE |